CLINICAL_TRIALS
trial_result
· 2022-12-08
Clinical Trial Update: Decitabine and HQP1351-based Chemotherapy Regimen for the Treatment Advanced CML [Phase 2]
Summary
Phase 2 trial evaluating a decitabine and HQP1351-based chemotherapy regimen for advanced chronic myeloid leukemia with blast crisis/transformations.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation | Phase 2 | Status: UNKNOWN